uniQure NV (QURE)
22.69
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 21, 16:00
23.88
+1.19
(+5.24%)
Pre-Market: 07:59
uniQure Gross Profit Margin (Quarterly) : 10.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.00% |
| March 31, 2026 | 10.86% |
| December 31, 2025 | 38.85% |
| September 30, 2025 | -8.89% |
| June 30, 2025 | 18.55% |
| March 31, 2025 | -201.5% |
| December 31, 2024 | 4.71% |
| September 30, 2024 | -75.21% |
| June 30, 2024 | 8.94% |
| March 31, 2024 | -39.72% |
| December 31, 2023 | -94.69% |
| September 30, 2023 | -156.1% |
| June 30, 2023 | -62.68% |
| March 31, 2023 | 6.82% |
| December 31, 2022 | 96.13% |
| September 30, 2022 | -104.6% |
| June 30, 2022 | -466.0% |
| March 31, 2022 | -18.42% |
| December 31, 2021 | 93.67% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 94.61% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | |
| September 30, 2016 | 75.93% |
| June 30, 2016 | 62.19% |
| March 31, 2016 | 55.88% |
| December 31, 2015 | 59.13% |
| September 30, 2015 | 54.83% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 53.80% |
| September 30, 2014 | 45.15% |
| June 30, 2014 | 84.07% |
| March 31, 2014 | 87.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Kymera Therapeutics, Inc. | 96.88% |
| Moderna, Inc. | -7.59% |
| Abivax SA | -- |
| GRAIL, Inc. | -30.61% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -140.6% |
| Return on Assets | -31.04% |
| Return on Invested Capital | -35.17% |
| Profit Margin (Quarterly) | -1.39K% |
| Operating Margin (Quarterly) | -899.6% |
| Return on Net Operating Assets | -176.6% |